In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Ernexa Therapeutics Inc (NASDAQ: ERNA) closed at $0.22 in the last session, up 0.46% from day before closing price of $0.22. In other words, the price has increased by $0.46 from its previous closing price. On the day, 0.61 million shares were traded.
Ratios:
We take a closer look at ERNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.21 and its Current Ratio is at 0.21.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 02 ’25 when Cherington Charles bought 3,768,397 shares for $0.10 per share. The transaction valued at 394,174 led to the insider holds 20,401,602 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 25.30.
Stock Price History:
Over the past 52 weeks, ERNA has reached a high of $2.62, while it has fallen to a 52-week low of $0.15. The 50-Day Moving Average of the stock is 4.52%, while the 200-Day Moving Average is calculated to be -65.27%.
Shares Statistics:
A total of 52.25M shares are outstanding, with a floating share count of 20.84M. Insiders hold about 66.58% of the company’s shares, while institutions hold 2.39% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
